摘要
目的观察复方丹参滴丸治疗冠心病心绞痛的临床疗效。方法治疗组(50例)口服复方丹参滴丸,每日3次,每次10粒,共12周;对照组(50例)口服消心痛,每日3次,每次10mg,共12周。比较两组的心绞痛症状、心电图及血液流变学各项指标。结果治疗组与对照组比较,治疗组的心绞痛症状、心电图改善及血液流变学指标明显优于治疗前及对照组(P<0.05或P<0.01)。结论复方丹参滴丸是治疗冠心病心绞痛安全有效的药物。
[Objective] To observe the clinical therapeutic effect of salvia mihiorrhiza guttate in treatment of coronary heart disease with anginapectoris. [Methods] The treated group（50cases） was treated with salvia miltiorrhiza guttate by taken orally three times a day for 12 weeks. The control group（50cases） was given Isosorbidi Dinitras. The clinical therapeutic effect and the ECG effect rate were observed and all hemorrheological parameters were examined before and after treatment respectively and compared. [Results] After treatment, the clinical therapeutic effect and the ECG effect rate and the hemorrheological parameters in treated group were improved than those before treatment and those of control group （P 〈0.05 or P 〈0.01）. [Conclusions] Salvia miltiorrhiza guttate is an effective and safe therapy in treating coronary heart disease with anginapectoris.
出处
《中国现代医学杂志》
CAS
CSCD
北大核心
2005年第22期3485-3487,共3页
China Journal of Modern Medicine
关键词
复方丹参滴丸
冠心病心绞痛
血液流变性
salvia mihiorrhiza guttate
coronary heart disease
anginapectoris
hemorrheology
